Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy.
Level III
Where this comes from
- Record sourced from PubMed, PMID 28492921.
- Also identified by DOI 10.1001/jamaophthalmol.2017.0969 and PMC identifier 5847077.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This Research Letter compares treatment with intraviterous ranibizumab with undergoing panretinal photocoagulation for managing proliferative diabetic retinopathy.
Medical subject headings
- Angiogenesis Inhibitors
- Diabetic Retinopathy
- Information Dissemination
- Laser Coagulation
- Ranibizumab
- Retinal Neovascularization